What are the advantages of ultra-long-acting insulin analogs, and how do they improve glycemic control compared to shorter-acting formulations?
Share
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Ultra-long-acting insulin analogs provide stable insulin levels, reducing the risk of hypoglycemia and improving fasting glucose levels compared to shorter-acting types.